Author: Bamberger Tynan - Page 5

Medicaid Generic Drug Policies: How States Are Cutting Prescription Costs

States are using MAC lists, price gouging laws, and PBM transparency to control Medicaid spending on generic drugs. With 84% of prescriptions being generics, these strategies are key to keeping costs down-but they come with risks.

Read More

Consumer Protection Laws for Patients: What You Need to Know in 2025

New York's 2024 patient protection laws stop hospitals from forcing credit card payments, require separate consent for treatment and billing, and ban providers from filling out medical financing apps. Know your rights before signing anything.

Read More

Weight Management During Psychotropic Medications: What Works and What Doesn’t

Psychotropic medications often cause significant weight gain, increasing risks for diabetes and heart disease. Learn which drugs are worst, how to manage it, and what strategies actually work to protect your health without sacrificing mental health stability.

Read More

How to Handle Missed Pediatric Medication Doses Safely

Learn how to safely handle missed pediatric medication doses without doubling up. Follow time-based rules for once-daily, twice-daily, and other schedules. Avoid dangerous errors and protect your child's health.

Read More

Specialty Pharmacy: How Providers Dispense Generic Specialty Drugs

Specialty pharmacies dispense generic specialty drugs under the same strict rules as brand-name versions. Learn why cost doesn’t change the process - and how providers ensure safe, consistent care.

Read More

PSA Screening Controversies: Why Shared Decision-Making Matters for Prostate Cancer

PSA screening for prostate cancer saves some lives but causes many unnecessary treatments. Shared decision-making ensures men understand the risks and benefits before testing.

Read More

Autoimmune Disease Monitoring: Lab Markers, Imaging, and Visits

Autoimmune disease monitoring relies on lab markers like CRP and ANA, imaging such as MRI and ultrasound, and regular clinical visits to catch flares early and prevent organ damage. This guide breaks down what works, what doesn’t, and how to stay ahead of your condition.

Read More

Sulfonylureas and Hypoglycemia: How to Lower Your Risk of Low Blood Sugar

Sulfonylureas are effective but carry a high risk of low blood sugar. Learn which types are safest, who's most at risk, and how to prevent dangerous hypoglycemia with practical, evidence-based strategies.

Read More

DMARDs and Biologic Medications: What You Need to Know About Immunosuppressive Therapy

DMARDs and biologic medications are key treatments for autoimmune diseases like rheumatoid arthritis. They stop immune system damage, not just symptoms. Learn how they work, who gets them, and what to expect.

Read More

Bioavailability Studies for Generics: What They Test and Why

Bioavailability studies ensure generic drugs work like brand-name versions by measuring how much and how fast the active ingredient enters the bloodstream. The FDA uses strict criteria to approve generics without full clinical trials.

Read More

FDA Inspection of Generic Manufacturing Facilities: What to Expect in 2025

Understand what happens during an FDA inspection of generic drug manufacturing facilities, from Pre-Approval Inspections to FDA 483 responses and how to maintain CGMP compliance in 2025.

Read More

Opioids in Liver Disease: How Impaired Metabolism Increases Toxicity Risk

Opioids can become dangerously toxic in liver disease due to impaired metabolism. Learn how morphine and oxycodone accumulate, why buprenorphine may be safer, and what dosing changes are needed to avoid life-threatening side effects.

Read More